Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
You can reach our customer support team by email at [email protected]
Clinical Efficacy: Evidence from Major Trials Weight Loss Outcomes in Non-Diabetic Patients The clinical efficacy of GLP-1 agonists for weight loss in non-diabetic patients has been demonstrated across multiple large-scale randomized controlled trials
Prior studies have identified the insula as a key region implicated in smoking behavior and nicotine dependence ( However, most previous studies were conducted in general smoking populations without metabolic comorbidities and relied primarily on behavioral outcomes ( In summary, by focusing on patients with T2DM, extending follow-up duration, and integrating functional MRI assessments, this trial aims to address important gaps regarding the potential effects of GLP-1RAs on smoking-related behaviors and their neurobiological mechanisms
Cc liu trnh c xy dng vi mc tiu ci thin sng ca ln da, ng thi nui dng nn da khe mnh, gip hiu qu duy tr bn vng hn m khng cn can thip bng ng truyn tnh mch
